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Clinical Implications128 A single food allergy education session targeting school
nurses increased the availability of epinephrine to
children with food allergies, and this effect was sustained
over 2 years. This study details a feasible model to
increase the nationwide school availability of this
lifesaving treatment.TO THE EDITOR:
Food allergy is a serious disease that affects 5% of US chil-
dren.1 Approximately 18% to 23% of children with food al-
lergies experience reactions in the school setting, which accounts
for 28% of anaphylaxis fatalities.2,3 One critical risk factor of
death from anaphylaxis is delay in epinephrine administration.4
Readily accessible injectable epinephrine devices are integral to
the safety of children with food allergies.5 In addition, lower
socioeconomic schools have been shown to have fewer injectable
epinephrine devices than non-low socioeconomic schools.5
Recently President Obama signed into law the School Access to
Emergency Epinephrine Act, which provides incentives for states
to require schools to stock epinephrine.6
Training for school personnel is an essential component of
epinephrine device placement in schools. In Texas, only student-
speciﬁc epinephrine is allowed; every child with a food allergy
must have on-site, prescribed epinephrine to receive anaphylaxis
treatment. We hypothesized that a single didactic session tar-
geting Houston Independent School District nurses would in-
crease the identiﬁcation of children with food allergies, decrease
allergic reactions, and increase the availability of student-speciﬁc
injectable epinephrine devices in both low and non-low socio-
economic schools.
Evaluation of the number of childrenwith food allergies, allergic
reactions, and injectable epinephrine devices before and 2 years
after a 2011 didactic session with school nurses was performed.
Education addressed allergic reaction symptoms and treatment
with case studies and hands-on injectable epinephrine device
practice (Table I). The number of children with food allergies and
injectable epinephrine devices was obtained from 2 control school
districts. School socioeconomic status was based on the National
School Lunch Program. Low socioeconomic schools were deﬁned
as those with 70% student participation in the National School
Lunch Program, and non-low socioeconomic schools had <70%
participation. The Wilcoxon signed ranked test was utilized to
compare the number of children with food allergies, allergic re-
actions, and injectable epinephrine devices.
Sixty-two nurses representing approximately 61,000 students
per year responded to the surveys, with 39 responding for all the
study years (2010 to 2013). In both 2010 and 2012, 84% ofschools were low socioeconomic schools. Although there were
signiﬁcantly more injectable epinephrine devices per school in
non-low than in low socioeconomic schools both pre- and
posteducation, both experienced a statistically signiﬁcant increase
in injectable epinephrine devices posteducation (Table II). This
signiﬁcant increase was seen when the total number of
responding schools was compared (Table IIa) and when only
schools measured in both years were analyzed (Table IIb). There
was no statistically signiﬁcant difference in the amount of in-
crease of injectable epinephrine devices based on socioeconomic
status (P ¼ .07).
Notably, from 2010 to 2012, allergic reactions decreased with
15% of children with food allergies reacting in 2010 and 0% in
2012 (P ¼ .014), and the number of student-speciﬁc injectable
epinephrine devices increased (P < .001). This effect was sus-
tained in 2013 without continued education. From 2010 to
2012, the correlation of injectable epinephrine devices to chil-
dren with food allergies increased (Figure 1). From 2012 to
2013, the intervention district had a posteducation ratio of an
epinephrine device to a child with food allergy of 0.77 compared
with that of a control district (0.185). In addition, a smaller
Texas control school district demonstrated no signiﬁcant increase
in the ratio of an epinephrine device to a child with food allergy
(0.08 to 0.1) from 2010 to 2013.
Targeted nursing education signiﬁcantly affected school pre-
paredness for allergic reactions to food, with an increased number
of student-speciﬁc injectable epinephrine devices per child with
food allergy and decreased allergic reactions. This one educa-
tional session eliminated allergic reactions to food in 2012. We
hypothesize that one of the mechanisms of this improvement was
the reviewing of school food avoidance techniques and education
on effective methods to prevent accidental exposures in the
school setting. Prevention is the most effective strategy in pro-
tecting children from food allergies. This drastic reduction in
allergic reactions to food argues for the importance of school
education regarding food allergies.
Nursing staff reported the educational intervention facilitated
identiﬁcation of symptoms associated with allergic reactions to
food, particularly clarifying the difference between asthma ex-
acerbations and allergic reactions to food. For example, wheezing
postexposure to food allergens was often treated with asthma
medications rather than epinephrine as indicated for anaphylaxis.
Previous studies have shown that school personnel have poor
understanding of anaphylaxis signs and symptoms and the use of
injectable epinephrine devices.7 Prompt recognition of symp-
toms of a food allergy is imperative for early administration of
lifesaving epinephrine.
Per nursing staff, the educational session increased awareness
of the need for and subsequent availability of physician-
composed food allergy action plans, which suggest a mechanism
for the increase in epinephrine availability. Food allergy action
plans document the patient’s food allergies as well as treatments
indicated with speciﬁc symptoms and are recommended for all
children with food allergies.2 The action plans in the intervention
schools emphasize the importance of epinephrine administration
in reactions and may be one mechanism by which injectable
epinephrine devices increased at these schools.
TABLE I. School education workshop content
Sessions Components
1. Didactic lecture entitled “Food Allergy 101” Recognition and management of food allergy
Education of parents and children
2. Group discussion of handouts including food allergy Assess type of reaction (mild vs life threatening)
Assess suitability of response (Benadryl vs epinephrine)
3. Practice session Determination of Benadryl dose (1 teaspoon/10 kg)
Epinephrine trainer groups of 2-3
4. Didactic lecture entitled “School Management of Food Allergies” School avoidance strategies
Components of school policy for management of students
with life-threatening allergies
5. Development individualized school policy
TABLE II. Number of schools, epinephrine devices and student number in 2010 and 2012
Number
of schools
Mean epinephrine
devices per school SD
P Value:
effect of SES
P Value:
effect of time
Mean Number of
students with food allergy SD
(a) For the total number of responding schools
2010 <.001
Non-low SES 12 5.83 3.41 17 15.92
Low SES 76 0.92 1.10 6.18 7.25
2012 <.001
Non-low SES 21 7.57 6.19 .0278 9.19 6.52
Low SES 116 1.68 1.94 .0001 1.92 2.47
(b) For schools with data for both 2010 and 2012
2010 <.001
Non-low SES 10 6.1 3.7 17.6 17.51
Low SES 51 1.04 1.22 6.25 7.85
2012 <.001
Non-low SES 10 8.9 6.3 .0278 10.7 6.65
Low SES 51 2.2 2.0 .0001 2.86 3.1
SD, Standard deviation; SES, socioeconomic schools.
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FIGURE 1. Posteducation there was improved correlation of
injectable epinephrine per child with food allergy. Spearman’s rank
correlation between the number of students with food allergy and
injectors increased from 2010 (r2 ¼ 0.43) to 2012 (r2 ¼ 0.82). In
contrast, the control district experienced no increase during that
time.
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CLINICAL COMMUNICATIONS 129Two other control school districts in Texas without food al-
lergy educational intervention showed the number of epineph-
rine devices to number of children with food allergies ratiossimilar to those of the Houston Independent School District pre-
education; thus, increased community awareness alone could not
account for this increase in number of epinephrine devices
posteducation in the Houston school district. To evaluate
whether this educational session could be effective in the setting
of limited resources, we compared low and non-low socioeco-
nomic schools. Patients of lower socioeconomic status experience
many factors that limit their access to medical care, including
lower health literacy8 and poorer understanding of the signs and
symptoms of food allergy. Despite these factors, a single school
nurse educational intervention was equally effective in low and
non-low socioeconomic schools. Longer term studies are needed
to assess if this intervention can effectively bridge the gap be-
tween the number of epinephrine devices in low and non-low
socioeconomic schools.
This single educational session made a dramatic and sustainable
impact on the availability of lifesaving epinephrine in a large urban
school district. Although the School Access to Emergency
Epinephrine Act will increase the availability of nonassigned
injectable epinephrine devices, education about food allergy, in-
dications for epinephrine device use, and increased availability of
assigned epinephrine devices are still needed. This single interven-
tion provides a model for a feasible, nationwide school food allergy
education plan to enhance the safety of children with food allergies.
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